4 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2249828/here-s-why-you-should-retain-conmed-cnmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2249828
Apr 03, 2024 - CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
zc:3360554627537906403
0
https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?source=feed_sector_healthcare
Apr 14, 2024 - Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should still be able to beat the Street. Read more here.
0
sa:-7898530187201749423
0
https://www.zacks.com/stock/news/2261767/conmed-cnmd-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2261767
Apr 24, 2024 - The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:8223459146460603212
0
https://www.zacks.com/stock/news/2253858/smith-nephew-snn-expands-in-australia-with-new-alliance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253858
Apr 11, 2024 - The latest partnership allows Smith+Nephew (SNN) to complement its existing implant range with the cutting-edge navigation technology of NAVBIT.
zc:-1261490857214792381
0